Latest News & Features
Biotechnology
The US International Trade Commission (USITC) will take another look at whether German orthopedics company Zimmer Biomet violated the IP rights of medical technology company Heraeus, it announced yesterday, Monday 13 July. 14 July 2020
Biotechnology
China’s Junshi Biosciences has licensed technology to produce an antibody against COVID-19 from Swiss biotechnology firm Lonza. 14 July 2020
article
UK Intellectual Property Office Perspective: Views on the Current Patenting Landscape - and COVID-19
Join the live broadcast to take part in the discussion with the UKIPO. Topics include: 14 July 2020
Generics
The EU’s top court has ruled out extra exclusivity rewards to drug companies for products with a second medical use. 10 July 2020
Biotechnology
The COVID-19 pandemic poses unprecedented challenges to the biomedical community as it strives to find the best solutions to fight COVID-19. 10 July 2020
Americas
The antitrust chief of the US Justice Department (DOJ) made a rare appearance in court when he requested that the US Court of Appeals for the Eleventh Circuit reject a defence used by a medical and dental board against an antitrust lawsuit. 9 July 2020
Europe
Drug company Teva has lost an appeal over its bid to trademark two word signs, after the tenth chamber of the EU General Court ruled in favour of the European Union IP Office (EUIPO) yesterday, July 8. 9 July 2020
Biotechnology
A Roche subsidiary will be unable to block Amgen from producing the cancer drug Mvasi (bevacizumab), the Court of Appeals for the Federal Circuit has ruled. 7 July 2020
article
Jakob Wested is currently working on repurposing of medicine with Johnathan Liddicoat from Cambridge which has some interesting perspectives around the current COVID situation. Jakob's contribution will touch upon issues of patenting second medical use as well as the complementarity between IPR and regulatory exclusivities. 7 July 2020
Europe
The European Patent Office has unveiled data sets relating to antiviral vaccines and pharmaceutical therapeutics as part of its new “Fighting coronavirus” platform. 6 July 2020